Marel de Wit

Marel de Wit has been working in the field of Regulatory Affairs since 2003. Marel began their career at Abbott B.V. as Manager Regulatory Affairs and then moved to Magenta Pharma Consulting as a Freelance Medical Writer in 2006. In 2011, they took on the role of Regulatory Project Manager at Abbott Biologicals, where they were responsible for supervising two Senior RA Officers. In 2015, they moved to Teva Pharmaceuticals as a Regulatory Affairs Officer. From 2017 to 2022, they worked at Pharming Group N.V. as an Associate Director RA and a Senior Regulatory Affairs Specialist. Finally, they are currently employed at Merus N.V. as Ass. Director RA.

Marel de Wit received a Drs in Medical Biology from Utrecht University between 1993 and 1998. Subsequently, they completed a PhD in Antiviral Immunology from the same university between 1998 and 2004.